Pharming PHAR
NASDAQ PHAR
$13.40 +0.38 (+2.95%)
As of: Nov 11, 2026 · 12:32 PM EST

Pharming (PHAR) Interest Coverage Ratio (2020 - 2021)

Updated

Pharming's (PHAR) Interest Coverage Ratio was 2.92 for Q4 2021, up 103.9% from 1.43 a year earlier.

Analysis

Pharming (PHAR) Interest Coverage Ratio (2020 - 2021) Analysis & Trends

For FY2021, Interest Coverage Ratio at Pharming was 1.95, down 16.9% from FY2020.

  • By year, Interest Coverage Ratio came in at 2.34 in FY2020 (-44.3%), 4.21 in FY2019 (+311.8%) and 1.02 in FY2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Cover (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 28.50
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 9.20
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 5.68
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 12.87
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Pharming 927.62 Mn 229.29 Mn 102.20 -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 2.92
Mar 31, 2021 0.95
Dec 31, 2020 1.43
API Access

Pharming Interest Coverage Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-coverage-ratio&ticker=PHAR&period=max&api_key=YOUR_API_KEY